Fjarde Ap Fonden 10x Genomics, Inc. Call Options Transaction History
Fjarde Ap Fonden
- $9.04 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TXG
# of Institutions
287Shares Held
97.2MCall Options Held
162KPut Options Held
107K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$180 Million2.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$171 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$107 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$103 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$103 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.59B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...